VBI Vaccines Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Jeff Baxter
Chief Executive Officer (CEO)
US$1.8m
Compensación total
Porcentaje del salario del CEO | 37.0% |
Permanencia del CEO | 8yrs |
Participación del CEO | 0.07% |
Permanencia media de la dirección | 6.7yrs |
Promedio de permanencia en la Junta Directiva | 6.3yrs |
Actualizaciones recientes de la dirección
Recent updates
VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook
Sep 22VBI Vaccines gets up to $100M debt funding from K2 HealthVentures
Sep 15Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe
Sep 08VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings
Aug 26VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis
Jun 17Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24VBI Vaccines: Hepatitis Vaccine Approval Can Be A Catalyst For >$1bn Valuation
Oct 31Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?
Oct 06VBI Vaccines: Turning My Focus To VBI-1901
Jul 15VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?
Jul 08Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$94m |
Sep 30 2023 | n/a | n/a | -US$115m |
Jun 30 2023 | n/a | n/a | -US$119m |
Mar 31 2023 | n/a | n/a | -US$120m |
Dec 31 2022 | US$2m | US$678k | -US$113m |
Sep 30 2022 | n/a | n/a | -US$111m |
Jun 30 2022 | n/a | n/a | -US$102m |
Mar 31 2022 | n/a | n/a | -US$73m |
Dec 31 2021 | US$3m | US$605k | -US$70m |
Sep 30 2021 | n/a | n/a | -US$66m |
Jun 30 2021 | n/a | n/a | -US$63m |
Mar 31 2021 | n/a | n/a | -US$56m |
Dec 31 2020 | US$2m | US$535k | -US$46m |
Sep 30 2020 | n/a | n/a | -US$42m |
Jun 30 2020 | n/a | n/a | -US$45m |
Mar 31 2020 | n/a | n/a | -US$49m |
Dec 31 2019 | US$1m | US$500k | -US$55m |
Sep 30 2019 | n/a | n/a | -US$63m |
Jun 30 2019 | n/a | n/a | -US$62m |
Mar 31 2019 | n/a | n/a | -US$66m |
Dec 31 2018 | US$1m | US$465k | -US$64m |
Sep 30 2018 | n/a | n/a | -US$56m |
Jun 30 2018 | n/a | n/a | -US$50m |
Mar 31 2018 | n/a | n/a | -US$43m |
Dec 31 2017 | US$826k | US$450k | -US$39m |
Compensación vs. Mercado: La compensación total de Jeff($USD1.83M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Jeff ha sido consistente con los resultados de la empresa en el último año.
CEO
Jeff Baxter (62 yo)
8yrs
Permanencia
US$1,830,436
Compensación
Mr. Jeffery R. Baxter, also known as Jeff, FCMA, has been the Chief Executive Officer and President of VBI Vaccines Inc. since May 2016. Mr. Baxter has been the Chief Executive Officer and President of VBI...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 8yrs | US$1.83m | 0.071% $ 11.6k | |
Chief Scientific Officer | 8yrs | US$995.44k | 0.017% $ 2.8k | |
Chief Medical Officer | 8.3yrs | US$1.01m | 0.049% $ 8.0k | |
CFO, Head of Corporate Development & Director | 1.1yrs | sin datos | 0.0080% $ 1.3k | |
Director of Corporate Communications & Investor Relations | no data | sin datos | sin datos | |
Senior VP of Finance | 6.7yrs | sin datos | sin datos | |
Global Head of Manufacturing & GM of SciVac | 7yrs | sin datos | 0.025% $ 4.1k | |
Senior VP of Global Commercial Supply Strategy & Head of Europe | 4.3yrs | sin datos | sin datos | |
Senior Vice President of Business Development | 4.3yrs | sin datos | sin datos | |
Chief Commercial Officer | 1.8yrs | sin datos | sin datos |
6.7yrs
Permanencia media
56.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de VBIV es experimentado (6.6 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 8yrs | US$1.83m | 0.071% $ 11.6k | |
CFO, Head of Corporate Development & Director | 1.1yrs | sin datos | 0.0080% $ 1.3k | |
Independent Chairperson of the Board | 8yrs | US$215.59k | 0.0099% $ 1.6k | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Member of Scientific Advisory Board | 6.3yrs | sin datos | sin datos | |
Member of Scientific Advisory Board | no data | sin datos | sin datos | |
Chairperson of the Commercial Advisory Board & Independent Director | 4.2yrs | US$139.88k | 0% $ 0 | |
Independent Director and Chair of Scientific & Clinical Advisory Boards | 8yrs | US$132.33k | 0.0059% $ 957.2 | |
Independent Director | 5.3yrs | US$144.83k | 0% $ 0 | |
Independent Director | 5.1yrs | US$147.33k | 0% $ 0 | |
Member of Scientific Advisory Board | 6.3yrs | sin datos | sin datos | |
Member of Scientific Advisory Board | 6.3yrs | sin datos | sin datos |
6.3yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de VBIV se considera experimentada (6.3 años de antigüedad promedio).